Planta Med 2006; 72(4): 346-350
DOI: 10.1055/s-2005-916231
Original Paper
Physiology and in vitro Biotechnology
© Georg Thieme Verlag KG Stuttgart · New York

Efficient Preparation of Derivatives of Resibufogenin using Microbial Catalytic Technique

Jixun Zhan1 , 2 , Hongzhu Guo1 , Lili Ning1 , Yuanxing Zhang2 , Dean Guo1
  • 1The State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, P. R. China
  • 2State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, P. R. China
Further Information

Publication History

Received: July 5, 2005

Accepted: September 20, 2005

Publication Date:
30 January 2006 (online)

Abstract

Microbial catalysis is a useful biotechnology in studies on natural products, by which a diversity of novel or active compounds can be obtained. Structural modifications of resibufogenin (1) by hydroxylases, isomerase and glucosyltransferase in Mucor subtilissimus AS 3.2454 were investigated. Eleven products were obtained, and, on the basis of their spectral data, their structures were identified as 12β-hydroxyresibufogenin (2), 11β-hydroxyresibufogenin (3), 16α-hydroxyresibufogenin (4), 12β-hydroxy-3-epi-resibufogenin (5), 12α-hydroxyresibufogenin (6), 1β,11β-dihydroxyresibufogenin (7), 12β,16α-dihydroxyresibufogenin (8), 12α,16α-dihydroxyresibufogenin (9), 7α-hydroxyresibufogenin (10), 1β,12β-dihydroxyresibufogenin (11) and resibufogenin 12-O-β-D-glucoside (12), respectively, of which 3, 5, 7, 11 and 12 are new compounds. This microbial catalytic process was efficient for the production of derivatives of resibufogenin giving 11 products and an overall yield of 93.60 %.

References

  • 1 Chen Y, Xiang J, Gu W, Xu M. Chemical constituents of Bufo Siccus .  China J Chin Mater Med. 1998;  23 620-1
  • 2 Krenn L, Kopp B. Bufadienolides from animal and plant sources.  Phytochemistry. 1998;  48 1-29
  • 3 Xie J T, Wang H S, Attele A S, Yuan C S. Effect of resibufogenin from toad venom on isolated Purkinje fibers.  Am J Chin Med. 2000;  28 187-96
  • 4 Xie J T, Dey L, Wu J A, Lowell T K, Yuan C S. Cardiac toxicity of resibufogenin: electrophysiological evidence.  Acta Pharmacol Sin. 2001;  22 289-97
  • 5 Kamano Y, Kotake A, Hashima H, Inoue M, Morita H, Takeya K. et al . Structure-cytotoxic activity relationship for the toad poison bufadienolides.  Bioorg Med Chem. 1998;  6 1103-15
  • 6 Terness P, Navolan D, Dufter C, Kopp B, Opelz G. The T-cell suppressive effect of bufadienolides: Structural requirements for their immunoregulatory activity.  Int Immunopharmacol. 2001;  1 119-34
  • 7 Nogawa T, Kamano Y, Yamashita A, Pettit G R. Isolation and structure of five new cancer cell growth inhibitory bufadienolides from the Chinese Traditional Drug Ch’an Su.  J Nat Prod. 2001;  64 1148-52
  • 8 Kamano Y, Pettit G R, Inoue M, Tozawa M, Smith C R, Weisleder D. Synthesis of the 14α- and 16α-epimers of bufotalin acetate and 16-deacetylcinobufagin. J Chem Soc Perkin Trans I 1998: 2037-41
  • 9 Gsell L, Christoph T. Reactions with microorganisms. XVI. Toad poison (bufadienolide) conversion by microorganisms. IV. 7β-Hydroxybufalin, 7β-hydroxyresibufogenin, 12α-hydroxyresibufogenin.  Helv Chim Acta. 1969;  52 150-65

Dr. Dean Guo

The State Key Laboratory of Natural and Biomimetic Drugs

School of Pharmaceutical Sciences

Peking University

Beijing 100083

People’s Republic of China

Phone: +86-10-8280-1516

Fax: +86-10-8280-2700

Email: gda@bjmu.edu.cn

    >